Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

50.70
Delayed Data
As of Dec 02
 +0.55 / +1.10%
Today’s Change
29.50
Today|||52-Week Range
59.41
+7.67%
Year-to-Date
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors
Dec 01 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Expands Distribution Deal with Roche
Dec 02 / Zacks.com - Paid Partner Content
Achillion, J&J to Initiate Phase IIb Study on HCV Combo
Dec 01 / Zacks.com - Paid Partner Content
5 Stocks with Solid Net Profit Margin to Bet On
Dec 02 / Zacks.com - Paid Partner Content
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
Zacks.com featured highlights: Forestar Real Estate Group, McDermott International, C...
Nov 30 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase II Study on UX007
Dec 01 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close50.15
Today’s open49.90
Day’s range49.25 - 50.95
Volume256,169
Average volume (3 months)376,855
Market cap$1.6B
Dividend yield--
Data as of 4:02pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-2.76%
Earnings growth (this year)+15.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+15.67%
P/E ratio24.9
Price/Sales3.54
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...+0.74+5.43%
LXRXLexicon Pharmaceutic...+0.35+2.39%
SRPTSarepta Therapeutics...+0.46+1.43%
PBYIPuma Biotechnology I...+0.50+1.27%
Data as of 4:01pm ET, 12/02/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$1.05
Annual revenue (last year)$433.3M
Annual profit (last year)$57.2M
Net profit margin13.19%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts


Search for Jobs